Developing medical treatments for alcohol use disorders (AUD) may benefit from identifying molecules that underlie behavioral responses to alcohol. Forward genetics and candidate gene screens using C. elegans have identified molecules required for behavioral responses to alcohol, including the BK potassium channel, which is a direct target of alcohol, as well as the CRF and SWI/SNF pathways, which modify alcohol responses. These and other molecules identified in C. elegans appear to work in conserved ways in mammalian models of AUD and humans. Despite their success, genetic screens likely miss other genes of large effect if, for example, those genes are essential for development, functionally redundant, or are rare. By leveraging natural phenotypic and genetic variation in 200 wild isolates from across the globe, rather than mutagenesis using the lab strain N2, we uncovered new conserved genes that contribute to alcohol sensitivity in C. elegans. Our genome-wide association study revealed four significant quantitative trait loci (QTLs), three of which have never been implicated in alcohol response in nematodes or mammals, as well as the BK channel gene,
slo-1, which validated our approach. Candidate QTL genes included an FBOXA gene located within an expanded cluster of other FBOX genes, an essential nuclear transporter gene, and a rare isoform-specific allele of protein kinase D (
dkf-2). Additionally, we found that deletion of
dkf-2 in an N2 background conferred high resistance to intoxication. One extremely resistant wild isolate, JU830, which harbors all resistant genotypes at the QTLs, was six standard deviations above mean resistance. In contrast to the small indel and SNP variation associated with the four QTL in other strains, closer inspection of the BK channel
slo-1 locus in JU830 identified large indels in a number of its introns as well as its 5'UTR. Our results suggest that C. elegans underwent selection for alcohol sensitivity and resistance in nature. The three novel genes identified here, especially the protein kinase D, might represent druggable targets for novel treatments for alcohol addiction and abuse.